Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations.
|
21558396 |
2011 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
The PIK3CA gene is mutated with high frequency in human breast cancers.
|
15254419 |
2004 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
The PIK3CA gene is mutated with high frequency in human breast cancers.
|
15254419 |
2004 |
Non-Small Cell Lung Carcinoma
|
|
0.700 |
CausalMutation
|
CLINVAR |
The PIK3CA gene is mutated with high frequency in human breast cancers.
|
15254419 |
2004 |
Macrodactylia of fingers
|
|
0.700 |
CausalMutation
|
CLINVAR |
Somatic mosaicism of the PIK3CA gene identified in a Hungarian girl with macrodactyly and syndactyly.
|
26851524 |
2016 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Regorafenib in metastatic colorectal cancer.
|
24559322 |
2014 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
Non-Small Cell Lung Carcinoma
|
|
0.700 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
|
22357840 |
2012 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
Non-Small Cell Lung Carcinoma
|
|
0.700 |
CausalMutation
|
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Predictive biomarkers of sensitivity to the phosphatidylinositol 3' kinase inhibitor GDC-0941 in breast cancer preclinical models.
|
20453058 |
2010 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations predict local recurrences in rectal cancer patients.
|
19903786 |
2009 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.
|
19223544 |
2009 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
|
15805248 |
2005 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutations are not a major determinant of resistance to the epidermal growth factor receptor inhibitor cetuximab in metastatic colorectal cancer.
|
19366826 |
2009 |
Non-Small Cell Lung Carcinoma
|
|
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutation status in Japanese lung cancer patients.
|
16930767 |
2006 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials.
|
23066039 |
2013 |
ovarian neoplasm
|
|
0.700 |
CausalMutation
|
CLINVAR |
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
|
22271473 |
2012 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
ovarian neoplasm
|
|
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
Non-Small Cell Lung Carcinoma
|
|
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic.
|
15647370 |
2005 |
Mammary Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials.
|
22162582 |
2012 |
Colorectal Neoplasms
|
|
0.700 |
CausalMutation
|
CLINVAR |
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials.
|
22162582 |
2012 |